Market Tracker

10/31 7:05pm ET

Repros Therapeutics Inc (NASDAQ:RPRX)

6.34
Data as of Oct 31
 -0.41 / -6.07%
Today’s Change
5.92
Today|||52-Week Range
22.57
-65.36%
Year-to-Date

Today’s Trading

Previous close6.75
Today’s open6.75
Day’s range6.31 - 6.88
Volume925,022
Average volume (3 months)1,235,494
Market cap$156.0M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-12.71%
Earnings growth (this year)-13.66%
Earnings growth (next 5 years)-21.91%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.06

Competitors

 Today’s
change
Today’s
% change
DSCODiscovery Laboratori...-0.03-1.61%
RLMDRelmada Therapeutics...+0.03+0.85%
TRVNTrevena Inc+0.40+7.39%
DRNADicerna Pharmaceutic...-0.35-3.60%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$0.00
Annual profit (last year)-$27.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts